HC

Hemang Chandravadan Soni

Active Director Director DIN 11058905
DIN 11058905 First appointment Apr 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Hemang Chandravadan Soni

Data last updated:

Hemang Chandravadan Soni is a Director at Bryophyte Herbs Private Limited (since 2025). The company operates in Healthcare.

DIN 11058905
Primary Designation Director
Industry Healthcare
First Appointment 16 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bryophyte Herbs Private Limited U21003GJ2025PTC161609
Director16 Apr 20252025Active

Directorship timeline

Open interactive timeline →
Bryophyte Herbs Private Limited
Premium access

Shareholding and investment profile for Hemang Chandravadan Soni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemang Chandravadan Soni

Hemang Chandravadan Soni currently holds 1 directorship: Bryophyte Herbs Private Limited (Director, since 16 Apr 2025).

Hemang Chandravadan Soni was first appointed on 16 Apr 2025 as Director at Bryophyte Herbs Private Limited.

The current boards of Hemang Chandravadan Soni's companies include Bharatbhai Bhikhabhai Detroja (Bryophyte Herbs Private Limited), Hardeepsinh Harendrasinh Jadeja (Bryophyte Herbs Private Limited), Hardik Rameshchandra Purohit (Bryophyte Herbs Private Limited), Tarunbhai Masani (Bryophyte Herbs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available